Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Attal

Showing results (91-100 of 153) with videos related to

Pageof 16
Sort By:
Leukemia|March 9, 2007
Bone marrow mesenchymal stem cells are abnormal in multiple myelomaJ Corre, K Mahtouk, M Attal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1990
The CD24 antigen discriminates between pre-B and B cells in human bone marrowC Duperray, J M Boiron, C Boucheix, et al.
Leukemia|December 1, 1994
Trisomy 11 in acute myeloid leukemia: ten casesC Bilhou-Nabera, J F Lesesve, G Marit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2000
Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Groupe d'Etudes des Lymphomes de l'AdulteC Haioun, C Besson, E Lepage, et al.
Blood|June 1, 1995
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myelomaJ L Harousseau, M Attal, M Divine, et al.
Bone Marrow Transplantation|March 1, 1993
Risk factors for cytomegalovirus infection in BMT recipients transfused exclusively with seronegative blood productsH Rubie, M Attal, A M Campardou, et al.
Leukemia|January 1, 1992
Is allogeneic bone marrow transplantation the best treatment for young adult patients with acute myeloid leukemia in first complete remission. The BGMT GroupJ Reiffers, A M Stoppa, F Rigal-Huguet, et al.
Stem Cells (Dayton, Ohio)|August 1, 1995
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma. A report of the French Registry on Autologous Transplantation in Multiple MyelomaJ L Harousseau, M Attal, M Divine, et al.
Blood|April 15, 1995
Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (SFGM)A Devergie, D Blaise, M Attal, et al.
Leukemia|January 15, 2010
Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexaméthasoneH Avet-Loiseau, J Soulier, J-P Fermand, et al.
Pageof 16

Showing results (91-100 of 153) with videos related to

Sort By:
Pageof 16
Leukemia|March 9, 2007
Bone marrow mesenchymal stem cells are abnormal in multiple myelomaJ Corre, K Mahtouk, M Attal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1990
The CD24 antigen discriminates between pre-B and B cells in human bone marrowC Duperray, J M Boiron, C Boucheix, et al.
Leukemia|December 1, 1994
Trisomy 11 in acute myeloid leukemia: ten casesC Bilhou-Nabera, J F Lesesve, G Marit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2000
Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Groupe d'Etudes des Lymphomes de l'AdulteC Haioun, C Besson, E Lepage, et al.
Blood|June 1, 1995
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myelomaJ L Harousseau, M Attal, M Divine, et al.
Bone Marrow Transplantation|March 1, 1993
Risk factors for cytomegalovirus infection in BMT recipients transfused exclusively with seronegative blood productsH Rubie, M Attal, A M Campardou, et al.
Leukemia|January 1, 1992
Is allogeneic bone marrow transplantation the best treatment for young adult patients with acute myeloid leukemia in first complete remission. The BGMT GroupJ Reiffers, A M Stoppa, F Rigal-Huguet, et al.
Stem Cells (Dayton, Ohio)|August 1, 1995
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma. A report of the French Registry on Autologous Transplantation in Multiple MyelomaJ L Harousseau, M Attal, M Divine, et al.
Blood|April 15, 1995
Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (SFGM)A Devergie, D Blaise, M Attal, et al.
Leukemia|January 15, 2010
Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexaméthasoneH Avet-Loiseau, J Soulier, J-P Fermand, et al.
Pageof 16